Current Role at Stanford
Emma manages the Neurology & Neurosurgery Clinical Trials Team consisting of 17 Clinical Research Coordinators conducting 70+ clinical trials in areas including: Device Neurosurgery, Functional Neurosurgery, Headache, Epilepsy, Neuroimmunology, Alzheimers/Memory Disorders, Parkinson's, Radiology, and Bio Banks.
Education & Certifications
MPH, University of California Berkeley, Health Policy and Management (2021)
BS, Carnegie Mellon University (2012)
DEFUSE3: Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3, Stanford University (December 1, 2015)
DEFUSE 3 is a Stanford run prospective, randomized, multi-center, Phase III, adaptive, blinded endpoint, controlled trial. A maximum of 476 patients will be randomized and treated between 6 and 16 hours of symptom onset. Subjects will be randomized 1:1 to endovascular therapy plus medical management or medical management alone.
780 welch road, palo alto ca